Digest Network Come funziona
Network
/
Società
Ae
Non verificato

AeroRx Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute

3 comunicati stampa

Guarda tutti i comunicati
18/05/2026
Eventi
Fiere
Industria
Biotecnologia
Sanità
Salute
Terza età
Farmaceutica
Scienza
Attrezzature medico-sanitarie
Vetrine/Shopping
Medicina - Varie
AeroRx Therapeutics Presents Positive Phase 2a Data for Inhaled AERO-007, the First Potential Nebulized LABA+LAMA Fixed-Dose Combination in Development for COPD
Fonte
AeroRx Therapeutics, Inc.
Emittente
Business Wire
1.00
0
07/10/2025
Salute
Igiene alimentare
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Industria
AeroRx Therapeutics Announces $21 Million Series A Financing to Advance Inhaled AERO-007, the First Nebulized LABA/LAMA for COPD, into Late-Stage Clinical Development
Fonte
AeroRx Therapeutics, Inc.
Emittente
Business Wire
1.00
0
30/07/2025
Biotecnologia
Sanità
Salute
Terza età
Farmaceutica
Scienza
Attrezzature medico-sanitarie
Vetrine/Shopping
Medicina - Varie
Industria
AeroRx Therapeutics Announces Topline Positive Phase 2a Data for Inhaled AERO-007, the First Nebulized LABA/LAMA Combination in Development for COPD
Fonte
AeroRx Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0